When advanced cardiac ultrasound imaging is needed for fast and confident diagnoses, Toshiba Medical, a Canon Group company, will showcase its AplioTM i900 at this year’s American Society of Echocardiography (ASE) 2017 annual meeting in Baltimore, Md., June 2–6, 2017 (Booth #313). The Aplio i900 system is the latest addition to the premium Aplio i-series ultrasound platform, providing cardiologists and cardiovascular sonographers an ultrasound solution with excellent imaging clarity and definition.

The D-Heart, manufactured by Genova, Italy-based D-Heart Srl, developed a four-lead smartphone-based electrocardiogram (ECG). It is compatible with both iOS and Android operating systems and can stream results to any smartphone via Bluetooth.

Patients at Terrebonne General Medical Center (TGMC) now have access to safe, high-quality interventional cardiac exams with the installation of Toshiba Medical’s InfinixTM-i Sky +. TGMC, a nationally recognized healthcare organization and home to one of the most advanced vascular interventional practices in the country, is the first healthcare provider in the United States to install the Infinix-i Sky +.

The U.S. Food and Drug Administration (FDA) has approved Cardiac Insight’s wearable electrocardiogram sensor, a device that provides physicians with immediate access to improved reporting and analysis of heartbeat data.

Treating today’s cancer patient no longer means simply targeting the cancer. Given the known cardiotoxicities of some established chemotherapies and the possibility that newer approaches may damage the heart, oncologists, cardiologists and imaging specialists now work together to detect and minimize the risk of treatment-induced heart failure.

The approval of two new Current Procedural Terminology (CPT) codes acknowledges echocardiographic myocardial strain imaging and myocardial contrast perfusion echocardiography as emerging technologies, often a necessary step before a code is promoted to payable status.

Organizations are working in sync to put a focus on mandating optimized radiation doses in nuclear cardiology studies performed across the nation and beyond.